Lonza said it will be investing CHF 5.8 million in a formulation plant for its Meta metaldehyde in Visp, Switzerland. The company said the plant will enable it to supply its own formulations, allowing Lonza to serve the market with metaldehyde as an active substance, as well as with ready-made slug pellets.
The plant is expected to come online in the second half of 2012.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Compelling solutions through strategic partnerships
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
BASF sells a majority stake in its coatings business to the investor Carlyle.
